Induction of TNF-alpha-converting enzyme-ectodomain shedding by pathogenic autoantibodies

International Immunology

Volumn 21, Issue 12, 2009, Pages 1341-1349

  Sisto, Margherita ^a   Lisi, Sabrina ^a   Lofrumento, Dario Domenico ^b   Frassanito, Maria Antonia ^a   Cucci, Liana ^a   D'Amore, Simona ^a   Mitolo, Vincenzo ^a   D'Amore, Massimo ^a  

^a UNIVERSITY OF BARI MEDICAL SCHOOL   (Italy)

^b UNIVERSITY OF SALENTO   (Italy)

Author keywords

Adalimumab; Autoantibodies; Epithelial cells; Shedding; TACE

Indexed keywords

ADALIMUMAB; MESSENGER RNA; TUMOR NECROSIS FACTOR ALPHA CONVERTING ENZYME;

ARTICLE; AUTOIMMUNE DISEASE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; EPITHELIUM CELL; FLOW CYTOMETRY; GENE ACTIVATION; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INTERNALIZATION; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN INDUCTION; PROTEIN LOCALIZATION; PROTEIN PROCESSING; PROTEIN PURIFICATION; PROTEIN SYNTHESIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SALIVARY GLAND; SJOEGREN SYNDROME; WESTERN BLOTTING;

ADAM PROTEINS; ANTIBODIES, ANTINUCLEAR; ANTIBODIES, MONOCLONAL; CELLS, CULTURED; EPITHELIAL CELLS; GENE EXPRESSION; HUMANS; SALIVARY GLANDS; SJOGREN'S SYNDROME; TUMOR NECROSIS FACTOR-ALPHA;

EID: 70450162079     PISSN: 09538178     EISSN: 14602377     Source Type: Journal    
DOI: 10.1093/intimm/dxp103     Document Type: Article

References (32)

1. Black, R. A., Rauch, C. T., Kozlosky, C. J. et al. 1997. A metalloproteinase disintegrin that releases tumour-necrosis factor-α from cells. Nature 385:729.
2. Moss, M. L., Jin, S. L., Becherer, J. D. et al. 1997. Cloning of a disintegrin metalloproteinase that processes precursor tumour-necrosis factor-α. Nature 385:733.
3. Edwards, D. R., Handsley, M. M. and Pennington, C. 2008. The ADAM metalloproteinases. Mol. Aspects Med. 29:258.
4. Killar, L., White, J., Black, R. and Peschon, J. 1998. Adamalysins. A family of metzincins including TNF-alpha converting enzyme (TACE). Ann. N. Y. Acad. Sci. 878:442.
5. Kawaguchi, N., Horiuchi, K., Becherer, J. D., Toyama, Y., Besmer, P. and Blobel, C. P. 2007. Different ADAMs have distinct influences on Kit ligand processing: Phorbol-ester-stimulated ectodomain shedding of Kitl1 by ADAM17 is reduced by ADAM19. J. Cell Sci. 120:943.
6. Schlöndorff, J., Becherer, J. D. and Blobel, C. P. 2002. Intracellular maturation and localization of the tumour necrosis factor alpha convertase (TACE). Biochem. J. 347:131.
7. Peiretti, F., Canault, M., Bernot, D. et al. 2003. Intracellular maturation and transport of tumor necrosis factor alpha converting enzyme. Exp. Cell Res. 285:278.
8. Brynskov, J., Foegh, P., Pedersen, G. et al. 2002. Tumour necrosis factor alpha converting enzyme (TACE) activity in the colonic mucosa of patients with inflammatory bowel disease. Gut 51:37.
9. Ackermann, C. and Kavanaugh, A. 2007. Tumor necrosis factor as a therapeutic target of rheumatologic disease. Expert Opin. Ther. Targets 11:1369.
10. Furst, D. E., Schiff, M. H., Fleischmann, R. M. et al. 2003. Adalimumab, a fully human anti tumor necrosis factor-alpha monoclonal antibody, and concomitant standard antirheumatic therapy for the treatment of rheumatoid arthritis: Results of STAR (Safety Trial of Adalimumab in Rheumatoid Arthritis). J. Rheumatol. 30:2563.
11. Ramos-Casals, M., Brito-Zerón, P., Muñoz, S. and Soto, M. J. and BIOGEAS STUDY Group. 2008. A systematic review of the off-label use of biological therapies in systemic autoimmune diseases. Medicine (Baltimore) 87:345.
12. Sisto, M., D'Amore, M., Scagliusi, P., Mitolo, V. and Lisi, S. 2008. Selective TNF-alpha gene silencing attenuates apoptosis in human salivary gland epithelial cells. Int. J. Immunopathol. Pharmacol. 21:1045.
13. Bzowska, M., Jura, N., Lassak, A., Black, R. A. and Bereta, J. 2004. Tumour necrosis factor-alpha stimulates expression of TNF-alpha converting enzyme in endothelial cells. Eur. J. Biochem. 271:2808.
14. Sens, D. A., Hintz, D. S., Rudisill, M. T., Sens, M. A. and Spicer, S. S. 1985. Explant culture of human submandibular gland epithelial cells: evidence for ductal origin. Lab. Investig. 52:559.
15. Kapsogeorgou, E. K., Dimitriou, I. D., Abu-Helu, R. F., Moutsopoulos, H. M. and Manoussakis, M. N. 2001. Activation of epithelial and myoepithelial cells in the salivary glands of patients with Sjögren's syndrome: High expression of intercellular adhesion molecule-1 (ICAM.1) in biopsy specimens and cultured cells. Clin. Exp. Immunol. 124:126.
16. Kapsogeorgou, E. K., Moutsopoulos, H. M. and Manoussakis, M. N. 2001. Functional expression of a costimulatory B7.2 (CD86) protein on human salivary gland epithelial cells that interacts with the CD28 receptor, but has reduced binding to CTLA4. J. Immunol. 166:3107.
17. Vitali, C., Bombardieri, S., Jonsson, R. et al. 2002. Classification criteria for Sjögren's syndrome: A revised version of the European criteria proposed by the American-European Consensus Group. Ann. Rheum. Dis. 61:554.
18. Lisi, S., Sisto, M., Soleti, R. et al. 2007. Fcgamma receptors mediate internalization of anti-Ro and anti-La autoantibodies from Sjögren's syndrome and apoptosis in human salivary gland cell line A-253. J. Oral Pathol. Med. 36:511.
19. Doedens, J. R. and Black, R. A. 2000. Stimulation-induced down-regulation of tumor necrosis factor-alpha converting enzyme. J. Biol. Chem. 275:14598.
20. Sisto, M., Lisi, S., Castellana, D. et al. 2006. Autoantibodies from Sjögren's syndrome induce activation of both the intrinsic and extrinsic apoptotic pathways in human salivary gland cell line A-253. J. Autoimmun. 27:38.
21. Mochizuki, S., Shimoda, M., Shiomi, T., Fujii, Y. and Okada, Y. 2004. ADAM 28 is activated by MMP-7 (matrilysin-1) and cleaves insulin-like growth factor binding protein-3. Biochem. Biophys. Res. Commun. 315:79.
22. Tachida, Y., Nakagawa, K., Saito, T. et al. 2008. Interleukin-1 beta up-regulates TACE to enhance alpha-cleavage of APP in neurons: resulting decrease in A beta production. J. Neurochem. 104:1387.
23. Morange, P. E., Tregouet, D. A., Godefroy, T. et al. 2008. Polymorphisms of the tumor necrosis factor-alpha (TNF) and the TNF-alpha converting enzyme (TACE/ADAM17) genes in relation to cardiovascular mortality: The Athero Gene study. J. Mol. Med. 86:1153.
24. Trifilieff, A., Walker, C., Keller, T., Kottirsch, G. and Neumann, U. 2002. Pharmacological profile of PKF242-484 and PKF241-466, novel dual inhibitors of TNF-alpha converting enzyme and matrix metalloproteinases, in models of airway inflammation. Br. J. Pharmacol. 135:1655.
25. Haga, S., Yamamoto, N., Nakai-Murakami, C. et al. 2008. Modulation of TNF-alpha-converting enzyme by the spike protein of SARS-CoV and ACE2 induces TNF-alpha production and facilitates viral entry. Proc. Natl Acad. Sci. USA 105:7809.
26. Ohta, S., Harigai, M., Tanaka, M. et al. 2001. Tumour necrosis factor-{alpha} (TNF-{alpha}) converting enzyme contributes to production of TNF-{alpha} in synovial tissues from patients with rheumatoid arthritis. J. Rheumatol. 28:1756.
27. Patel, I. R., Attur, M. G., Patel, R. N. et al. 1998. TNF-{alpha} convertase enzyme from human arthritis-affected cartilage: Isolation of cDNA by differential display, expression of the active enzyme, and regulation of TNF-{alpha}. J. Immunol. 160:4570.
28. Seifert, T., Kieseier, B. C., Ropele, S. et al. 2002. TACE mRNA expression in peripheral mononuclear cells precedes new lesions on MRI in multiple sclerosis. Mult. Scler. 8:447.
29. Ding, T., Li, L., Zhu, K., Huang, W. and Yang, Y. 2001. Relationship between the increase of secretion of sTNF alpha induced by lipopolysaccharides and the enhanced expression of TACE mRNA in HL-60 cells and adhesive cells from human spleen. J. Tongji Med. Univ. 21:265.
30. Majka, S., McGuire, P. G. and Das, A. 2002. Regulation of matrix metalloproteinase expression by tumor necrosis factor in a murine model of retinal neovascularization. Investig. Ophthalmol. Vis. Sci. 43:260.
31. Obeid, D., Nguyen, J., Lesavre, P. and Bauvois, B. 2007. Differential regulation of tumor necrosis factor-alpha-converting enzyme and angiotensin-converting enzyme by type I and II interferons in human normal and leukemic myeloid cells. Oncogene 26:102.
32. Soond, S. M., Everson, B., Riches, D. W. and Murphy, G. 2005. ERK-mediated phosphorylation of Thr735 in TNF alpha-converting enzyme and its potential role in TACE protein trafficking. J. Cell Sci. 118:2371.